BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11925720)

  • 1. [Treatment strategy of neuroendocrine tumors].
    Ducreux M; Baudin E; Schlumberger M
    Rev Prat; 2002 Feb; 52(3):290-6. PubMed ID: 11925720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine tumours of the gastrointestinal tract: Chemotherapy.
    Arnold R; Rinke A; Schmidt Ch; Hofbauer L
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):649-56. PubMed ID: 16183533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1].
    Scherübl H; Schaaf L; Raue F; Faiss S; Zeitz M
    Dtsch Med Wochenschr; 2004 Mar; 129(13):689-92. PubMed ID: 15026965
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic chemotherapy of advanced digestive neuroendocrine tumours.
    Rougier P; Ducreux M
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S202-6. PubMed ID: 10604131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of somatostatin analogues in the treatment of neuroendocrine tumours.
    Grozinsky-Glasberg S; Grossman AB; Korbonits M
    Mol Cell Endocrinol; 2008 May; 286(1-2):238-50. PubMed ID: 18037561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for gastro-enteropancreatic endocrine tumours.
    O'Toole D; Hentic O; Corcos O; Ruszniewski P
    Neuroendocrinology; 2004; 80 Suppl 1():79-84. PubMed ID: 15477723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
    Desai KK; Khan MS; Toumpanakis C; Caplin ME
    Minerva Gastroenterol Dietol; 2009 Dec; 55(4):425-43. PubMed ID: 19942827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy and biotherapy in the treatment of neuroendocrine tumours.
    Oberg K
    Ann Oncol; 2001; 12 Suppl 2():S111-4. PubMed ID: 11762335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy of neuroendocrine tumors].
    Droz JP; Flechon A; Lombard-Bohas C
    Rev Prat; 2002 Feb; 52(3):285-9. PubMed ID: 11925719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours.
    Toumpanakis C; Meyer T; Caplin ME
    Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):131-44. PubMed ID: 17382269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic neuroendocrine tumours.
    Alexakis N; Neoptolemos JP
    Best Pract Res Clin Gastroenterol; 2008; 22(1):183-205. PubMed ID: 18206821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine tumors of the gastrointestinal tract: systemic treatment.
    Oberg K
    Anticancer Drugs; 1994 Oct; 5(5):503-19. PubMed ID: 7858282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of endocrine gastrointestinal-pancreatic tumors with somatostatin analog octreotide].
    Arnold R; Neuhaus C; Trautmann ME
    Dtsch Med Wochenschr; 1992 Jul; 117(27):1067-71. PubMed ID: 1352235
    [No Abstract]   [Full Text] [Related]  

  • 14. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
    Auernhammer CJ; Jauch KW; Hoffmann JN
    Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromogranin a levels in diagnosis, treatment and follow-up of 42 patients with non-functioning pancreatic endocrine tumours.
    Nikou GC; Marinou K; Thomakos P; Papageorgiou D; Sanzanidis V; Nikolaou P; Kosmidis C; Moulakakis A; Mallas E
    Pancreatology; 2008; 8(4-5):510-9. PubMed ID: 18765956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurendocrine tumours of the appendix, colon and rectum: current surgical aspects].
    Rosato L; De Tomaa G; Mondini G; Bertone P; Fornari F; Orlassino R
    Chir Ital; 2007; 59(4):445-52. PubMed ID: 17966763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy in the treatment of neuroendocrine malignant tumors.
    Rougier P; Mitry E
    Digestion; 2000; 62 Suppl 1():73-8. PubMed ID: 10940691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-centre experience with octreotide in the treatment of different hypersecretory syndromes in patients with functional gastroenteropancreatic neuroendocrine tumors.
    Berković MC; Altabas V; Herman D; Hrabar D; Goldoni V; Vizner B; Zjacić-Rotkvić V
    Coll Antropol; 2007 Jun; 31(2):531-4. PubMed ID: 17847934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroendocrine tumors of the pancreas].
    Gorgone A; Calbo L; Melita G; Riso F; Tigano D; Barbuscia M
    Chir Ital; 1999; 51(4):309-12. PubMed ID: 10633841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic therapy of gastroenteropancreatic (GEP) tumors.
    Syrigos KN; Sitara D; Georgiou E; Harrington KJ
    Anticancer Res; 2002; 22(2B):1311-4. PubMed ID: 12168943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.